These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21306363)

  • 61. Impact of a Value-based Formulary on Medication Utilization, Health Services Utilization, and Expenditures.
    Yeung K; Basu A; Hansen RN; Watkins JB; Sullivan SD
    Med Care; 2017 Feb; 55(2):191-198. PubMed ID: 27579915
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The impact of copayments and safety nets on PBS expenditure.
    Sweeny K
    Aust Health Rev; 2009 May; 33(2):215-30. PubMed ID: 19563310
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The net cost of Alzheimer disease and related dementia: a population-based study of Georgia Medicaid recipients.
    Martin BC; Ricci JF; Kotzan JA; Lang K; Menzin J
    Alzheimer Dis Assoc Disord; 2000; 14(3):151-9. PubMed ID: 10994656
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Copayments for medications after June 30, 2010. Final rule.
    Department of Veterans Affairs
    Fed Regist; 2011 Feb; 76(35):9646-8. PubMed ID: 21351679
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cost sharing for breast cancer hormone therapy: How do dual eligible patients' copayment impact adherence.
    Ma S; Shepard DS; Ritter GA; Martell RE; Thomas CP
    PLoS One; 2021; 16(5):e0250967. PubMed ID: 34003865
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of monthly prescription cap on medication persistence among patients with hypertension, hyperlipidemia, or diabetes.
    Wang CC; Wei D; Farley JF
    J Manag Care Pharm; 2013 Apr; 19(3):258-68. PubMed ID: 23537460
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions.
    Karter AJ; Parker MM; Moffet HH; Ahmed AT; Schmittdiel JA; Selby JV
    Health Serv Res; 2009 Oct; 44(5 Pt 1):1640-61. PubMed ID: 19500161
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Medicaid prescription cost containment and schizophrenia: a retrospective examination.
    Farley JF
    Med Care; 2010 May; 48(5):440-7. PubMed ID: 20351586
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid population.
    Bae SJ; Paltiel AD; Fuhlbrigge AL; Weiss ST; Kuntz KM
    Value Health; 2008; 11(1):110-8. PubMed ID: 18237365
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Differences in the cost of antidepressants across state Medicaid programs.
    Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ
    J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Who cares what it costs to dispense a Medicaid prescription?
    Lamphere-Thorpe JA; Johnston WP; Kilpatrick KE; Norwood GJ
    Health Care Financ Rev; 1994; 15(3):9-24. PubMed ID: 10137800
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Financial impact of patients enrolled in a medication adherence program at an independent community pharmacy.
    Clifton CL; Branham AR; Hayes HH; Moose JS; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S109-S113. PubMed ID: 30006182
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Retrospective assessment of Medicaid step-therapy prior authorization policy for atypical antipsychotic medications.
    Farley JF; Cline RR; Schommer JC; Hadsall RS; Nyman JA
    Clin Ther; 2008 Aug; 30(8):1524-39; discussion 1506-7. PubMed ID: 18803994
    [TBL] [Abstract][Full Text] [Related]  

  • 74. How does Cash and Counseling affect costs?
    Dale SB; Brown RS
    Health Serv Res; 2007 Feb; 42(1 Pt 2):488-509. PubMed ID: 17244294
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Potential bias in medication adherence studies of prevalent users.
    Maciejewski ML; Bryson CL; Wang V; Perkins M; Liu CF
    Health Serv Res; 2013 Aug; 48(4):1468-86. PubMed ID: 23402554
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Does the association between prescription copayment increases and medication adherence differ by race?
    Wong ES; Maciejewski ML; Liu CF
    J Health Care Poor Underserved; 2013 Aug; 24(3):1317-30. PubMed ID: 23974401
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The impact of implementing a more restrictive prescription limit on Medicaid recipients. Effects on cost, therapy, and out-of-pocket expenditures.
    Martin BC; McMillan JA
    Med Care; 1996 Jul; 34(7):686-701. PubMed ID: 8676607
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Restricting patients' medication supply to one month: saving or wasting money?
    Domino ME; Olinick J; Sleath B; Leinwand S; Byrns PJ; Carey T
    Am J Health Syst Pharm; 2004 Jul; 61(13):1375-9. PubMed ID: 15287233
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Understanding dual enrollees' use of Medicare home health services: the effects of differences in Medicaid home care programs.
    Kenney G; Rajan S
    Med Care; 2000 Jan; 38(1):90-8. PubMed ID: 10630723
    [TBL] [Abstract][Full Text] [Related]  

  • 80. State Medicaid pharmacy payments and their relation to estimated costs.
    Adams EK; Kreling DH; Gondek K
    Health Care Financ Rev; 1994; 15(3):25-42. PubMed ID: 10137796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.